Company Filing History:
9 out of 34 
1 out of 1,603 
Years Active: 1997-2000
Title: Thomas S Arrhenius: Innovator in Immunoinflammatory Treatments
Introduction
Thomas S Arrhenius is a prominent inventor based in San Diego, CA (US), known for his significant contributions to the field of immunoinflammatory disease treatments. With a total of 9 patents to his name, Arrhenius has made remarkable strides in developing innovative solutions that address critical health issues.
Latest Patents
Among his latest patents is the invention titled "CS-1 peptidomimetics, compositions and methods of using the same." This invention contemplates a peptide that inhibits the binding between the VLA-4 receptor expressed on inflammatory leukocytes and the fibronectin CS-1 peptide expressed on endothelial cells involved in immunoinflammatory disease states. The patent also discloses pharmaceutical compositions containing the contemplated peptide and processes for treating immunoinflammatory conditions using a binding-inhibitory peptide.
Career Highlights
Throughout his career, Arrhenius has worked with notable companies such as Cytel Corporation and Sandoz GmbH. His work has been instrumental in advancing the understanding and treatment of immunoinflammatory diseases, showcasing his dedication to improving patient outcomes.
Collaborations
Some of his notable coworkers include Mariano J Elices and Federico C Gaeta, who have collaborated with him on various projects, contributing to the success of his innovations.
Conclusion
Thomas S Arrhenius stands out as a key figure in the realm of immunoinflammatory treatments, with a strong portfolio of patents that reflect his innovative spirit and commitment to healthcare advancements. His work continues to inspire future developments in the field.